Business● LowAug 28 · Aug 28, 2026, 11:00 AM
BioCryst is profitable. Now it wants to buy more rare disease drugs
GlobeAlert Desk · curated from CNBC · global
Rare disease drug development is getting a boost from new funding models and a growing group of smaller biotech buyers.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business44m agoBitcoin today: BTC quote and price this Saturday, November 7, 2026ClarínBusiness58m agoCard dollar today: how much it quotes this Saturday, November 07ClarínBusiness58m agoCCL Dollar today: how much it quotes this Saturday, November 07ClarínBusiness1h agoMEP Dollar today: how much it quotes this Saturday, November 07Clarín